Ownership history in GENERAL ATLANTIC, L.P. · 22 quarters on record
This page tracks every 13F SEC filing in which GENERAL ATLANTIC, L.P. reported a position in ROYALTY PHARMA (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 1,500,000 | — | 0% | 1.59% | $52.9M | $34.90 |
| 2025 Q2 | UNCHANGED | 1,500,000 | — | 0% | 1.49% | $54.0M | $35.43 |
| 2025 Q1 | UNCHANGED | 1,500,000 | — | 0% | 1.57% | $46.7M | $30.41 |
| 2024 Q4 | UNCHANGED | 1,500,000 | — | 0% | 1.36% | $38.3M | $24.75 |
| 2024 Q3 | UNCHANGED | 1,500,000 | — | 0% | 1.21% | $42.4M | $27.23 |
| 2024 Q2 | UNCHANGED | 1,500,000 | — | 0% | 1.24% | $39.6M | $25.18 |
| 2024 Q1 | UNCHANGED | 1,500,000 | — | 0% | 1.06% | $45.6M | $28.79 |
| 2023 Q4 | UNCHANGED | 1,500,000 | — | 0% | 0.60% | $42.1M | $26.44 |
| 2023 Q3 | UNCHANGED | 1,500,000 | — | 0% | 0.63% | $40.7M | $25.35 |
| 2023 Q2 | UNCHANGED | 1,500,000 | — | 0% | 0.73% | $46.1M | $28.52 |
As of 2025 Q4 — sorted by position size